Valproic Acid Improves Myoclonic Hyperkinesia in Huntington's Disease
Author Information
Author(s): Carsten Saft, Thorsten Lauter, Peter H Kraus, Horst Przuntek, Juergen E Andrich
Primary Institution: Department of Neurology, Huntington-Center NRW, St. Josef Hospital, Bochum, Germany
Hypothesis
Can valproic acid improve myoclonic hyperkinesia in patients with Huntington's Disease?
Conclusion
Valproic acid may be an effective alternative treatment for Huntington's Disease patients suffering from myoclonic hyperkinesia.
Supporting Evidence
- Seven out of eight patients showed improvement in myoclonic hyperkinesia after treatment with valproic acid.
- The UHDRS motor score improved from an initial mean of 73.1 to 60.2 after treatment.
- In three patients, the dosage of antidopaminergic medication could be reduced.
Takeaway
This study shows that valproic acid can help people with Huntington's Disease who have jerky movements, making it easier for them to move.
Methodology
Eight patients with myoclonic hyperkinesia were treated with valproic acid and assessed using the Unified Huntington's Disease Rating Scale (UHDRS) motor score before and after treatment.
Limitations
The study is limited by the small sample size and lack of a control group.
Participant Demographics
All participants were adult patients with Huntington's Disease, primarily exhibiting myoclonic hyperkinesia.
Statistical Information
P-Value
0.042
Statistical Significance
p = 0.042
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website